Fresenius Medical Care (FMS) Competitors

DaVita (NYSE:DVA) and Fresenius Medical Care (NYSE:FMS) are both large-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their valuation, dividends, institutional ownership, risk, media sentiment, community ranking, earnings, profitability and analyst recommendations.

Is DVA or FMS more profitable?

DaVita has a net margin of 6.61% compared to DaVita's net margin of 2.48%. Fresenius Medical Care's return on equity of 68.52% beat DaVita's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
DaVita	6.61%	68.52%	4.98%
Fresenius Medical Care	2.48%	5.29%	2.30%

Does the media prefer DVA or FMS?

In the previous week, Fresenius Medical Care had 8 more articles in the media than DaVita. MarketBeat recorded 16 mentions for Fresenius Medical Care and 8 mentions for DaVita. Fresenius Medical Care's average media sentiment score of 1.00 beat DaVita's score of 0.42 indicating that DaVita is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
DaVita	4 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Fresenius Medical Care	6 Very Positive mention(s)	2 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Neutral

Which has higher earnings and valuation, DVA or FMS?

DaVita has higher earnings, but lower revenue than Fresenius Medical Care. DaVita is trading at a lower price-to-earnings ratio than Fresenius Medical Care, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
DaVita	$12.14B	1.06	$691.53M	$8.80	16.72
Fresenius Medical Care	$21.05B	0.59	$540.07M	$0.89	23.90

Do analysts recommend DVA or FMS?

DaVita presently has a consensus target price of $144.67, suggesting a potential downside of 1.67%. Fresenius Medical Care has a consensus target price of $24.00, suggesting a potential upside of 12.83%. Given DaVita's higher probable upside, analysts plainly believe Fresenius Medical Care is more favorable than DaVita.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
DaVita	0 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.33
Fresenius Medical Care	1 Sell rating(s)	4 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.14

Do institutionals and insiders believe in DVA or FMS?

90.1% of DaVita shares are owned by institutional investors. Comparatively, 8.3% of Fresenius Medical Care shares are owned by institutional investors. 2.0% of DaVita shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Does the MarketBeat Community favor DVA or FMS?

DaVita received 87 more outperform votes than Fresenius Medical Care when rated by MarketBeat users. Likewise, 61.75% of users gave DaVita an outperform vote while only 54.05% of users gave Fresenius Medical Care an outperform vote.

Company	Underperform	Outperform
DaVita	Outperform Votes 494 61.75%	Underperform Votes 306 38.25%
Fresenius Medical Care	Outperform Votes 407 54.05%	Underperform Votes 346 45.95%

Which has more volatility & risk, DVA or FMS?

DaVita has a beta of 1.04, indicating that its stock price is 4% more volatile than the S&P 500. Comparatively, Fresenius Medical Care has a beta of 0.95, indicating that its stock price is 5% less volatile than the S&P 500.

Summary

DaVita beats Fresenius Medical Care on 13 of the 18 factors compared between the two stocks.